Description
A potent inhibitor of SRPK1 (IC50 = 5.9 nM); inhibits phosphorylation of SRSF1, an SRPK1 substrate, in PC3 cells (EC50 = 360 nM); increases expression of the anti-angiogenic VEGF-A165b splice variant in RPE cells; inhibits blood vessel growth and macrophage infiltration in the eyes of a mouse model of choroidal neovascularization (2 μg per eye)
Formal name: 5-(4-pyridinyl)-N-[2-[4-(2-pyridinylmethyl)-1-piperazinyl]-5-(trifluoromethyl)phenyl]-2-furancarboxamide
Synonyms:
Molecular weight: 507.5
CAS: 1818389-84-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Serine/Threonine Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Signaling||Research Area|Neuroscience|Ophthalmology